Company Updates

Viralytics Ltd (ASX:VLA) is an Australian ASX listed biotechnology cancer company focussed on developing viruses which selectively target cancer cells. OVIERVIEW: Lead product is CAVATAK™ with broad anti-cancer activity CAVATAK™ program: Completed five Australian Phase 1 trials with 28 patients Current US Phase 2  trial in melanoma patients Planned Phase 1/2 UK trial in lung, prostate, […]

The first Proprietary prototype EVestG Unit costing $1.3M will commence clinical trials in April at the Monash Alfred Psychiatry Research Centre (MAPrc) at the Alfred Hospital in Melbourne. Early trials will look at concussion (mTBI) in Sport and the monitoring of any long term effects. Research will also be undertaken in respect of road trauma. […]

The hidden issue of Australia’s growing waste management requirements is felt through every level of government.  The Australian Federal Government together with their State and City counterparts are continually writing policies and underwriting funding initiatives to reduce waste being dumped at landfill.  Sydney in particular is struggling to manage its limited landfill spaces, and as […]

With the telco industry constantly evolving it is a challenge for a new company to establish itself and operate profitably.  Retail Service Providers (RSPs) are faced with the prospect of committing significant investment to bring a complete range of telco products and services effectively to market. Sydney-based Inabox, with its primary brand Telcoinabox, has reversed […]

The equipment financing and leasing paradigm has shifted in Australia.  Before, small assets such as commercial kitchen equipment and computer hardware were difficult to finance as the property was unregistered and therefore at high risk of being sold with the financier losing money. This all changed with the introduction of the Personal Property Securities Register […]

Market Announcements Platform – Australian Securities Exchange PERTH, AUSTRALIA: March 22, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that a core patent has been granted in Australia (Registration no: 2009251209; Divisional of AU 2008200790). The broad claims of this patent cover Phylomer libraries as ‘composition-of-matter’ […]

On 8th March 2013 Relivit received its first tax refund under the R&D Tax Incentive program, worth $122,000 from the financial year 2011/12. This refund reinforces the fact that Relivit is developing its own IP through research and development. Relivit hopes that future R&D will also be recognised for this financial year and the next, especially […]

Maiden diamond drill hole at the Blanco Y Negro Mine Prospect intersected 19.45m @ 2.04% Cu, 1.06g/t Au and 550ppm Mo from 85.05m in DDHHU-001. The drilling confirms the presence of high grade copper and associated gold and molybdenum in a zone of brecciation and veining hosted in andesitic volcanics with a strike exceeding 500m. […]

ASX Release – Tuesday, 5 March 2013 Leading Interactive lottery business, Jumbo Interactive Limited (ASX:JIN), is pleased to announce another major step forward in its plans to expand into high-growth international lotteries, with the signing of an indefinite license and contract in Schleswig Holstein to sell official German lotto games via web and mobile within […]